Filters

Showing all 12 results

Please add widgets to the WooCommerce Filters widget area in Appearance > Widgets

12 products

  • S3121E SARS-CoV-2/InFluA/InFluB Rapid Antigen Test (Immunochromatography Assay)

    Brief

    SARS-CoV-2/InFluA/InFluB Rapid Antigen Test (Immunochromatography Assay) is intended for the qualitative detection of the SARS-CoV-2/InFluA/InFluB nucleocapsid protein in human nasopharyngeal or oropharyngeal swabs. Test results will be available for reading in 15-20 minutes. Positive results indicate the presence of viral antigens. This kit is for in vitro diagnostic use.

    Features

    • Accurate LOD 80TCID50 /ml, Specificity 100%
    • Convenient No instrument needed, easy to operate
    • Fast Result available in only 15-20 min

    Instruction

    Result interpretation

    Parameters

    Qualification CE

    Kit components

    No. Product Name Spec.
    S3121E-25
    SARS-CoV-2/InFluA/InFluB Rapid Antigen Test (Immunochromatography Assay)
    25 Test

    The kit components:

    • SARS-CoV-2/InFluA/InFluB Antigen Test Cassette (individually in a foil pouch with desiccant)
    • Sample Extraction Buffer
    • Swab
  • S3120E-H-SARS-CoV-2 Rapid Antigen Test for Self-testing

    Brief

    The SARS-CoV-2 Rapid Antigen Test (Immunochromatography Assay) for self-testing is authorized for home use with self-collected nasal swab samples to directly detect antigen of SARS-CoV-2 virus. With the help of this kit, people without professional training can also easily acquire their COVID-19 test result within 15-20 minutes.

    Features

    • Accurate Sensitivity 94.55%, Specificity 100%
    • Convenient No instrument needed, easy to operate
    • Fast Result available in only 15-20 min
    • Flexible Get tested anytime when you are free

    Instruction

    Result interpretation

    Parameters

    Qualification CE

    Kit components

    No. Product Name Spec.
    S3120E-1-H, S3120E-5-H SARS-CoV-2 Rapid Antigen Test (Immunochromatography Assay) 1 Test, 5 Tests

    The kit components:

    •  SARS-CoV-2-Antigen Test Cassette (with desiccant)
    • SARS-CoV-2 Sample Extraction Buffer
    • Swab
    • Plastic Waste Bag
  • S3132E SARS-CoV-2 S-RBD Antibodies Test (Colloidal Gold)

    Brief

    The SARS-CoV-2 S-RBD Antibodies Test (Colloidal Gold) is intended for the qualitative detection of the SARS-CoV-2 S-RBD Antibodies in human serum, plasma and whole blood sampled from individuals after vaccination or after the infection with SARS-CoV-2.

    Features

    Instruction

    Result interpretation

    Parameters

    Qualification CE
    Order information
    No. Product Name Spec.
    S3132E-25 SARS-CoV-2 S-RBD Antibodies Test (Colloidal Gold) 25T/kit
    The kit components:
    • SARS-CoV-2 S-RBD Antibodies Test Cassette
    • Diluent Buffer
    • Blood Lancet for Single Use
    • Dropper
    • Alcohol Pad
  • S3131E SARS-CoV-2 Neutralizing Antibodies Test (Colloidal Gold)

    Brief

    The SARS-CoV-2 Neutralizing Antibodies Test (Colloidal Gold) is intended for the qualitative detection of the SARS-CoV-2 Neutralizing Antibodies in human serum, plasma and whole blood sampled from individuals after vaccination or after the infection with SARS-CoV-2.

    Features

    Instruction

    Result interpretation

    Parameters

    Qualification CE
    Order information
    No. Product Name Spec.
    S3131E-25 SARS-CoV-2 Neutralizing Antibodies Test (Colloidal Gold) 25T/kit
    The kit components:
    • SARS-CoV-2 Neutralizing Antibodies Test Cassette
    • Sample Diluent Buffer
    • Blood Lancet for Single Use
    • Dropper
    • Alcohol Pad
  • S3109E SARS-CoV-2 Rapid Antigen Test (Colloidal Gold Method)

    Brief

    The SARS-CoV-2 Rapid Antigen Test (Colloidal Gold Method) is intended for the qualitative detection of the SARS-CoV-2 nucleocapsid protein in human nasopharyngeal or nasal swab sampled from individuals suspected of COVID-19.

    Parameters

    Testing Time 10-15 minutes
    Sensitivity 98.4%
    Specificity 98.1%
    Qualification CE

    Kit components

    No. Product Name Spec.
    S3109E-25 SARS-CoV-2 Rapid Antigen Test (Colloidal Gold Method) 25 tests
  • S3120E SARS-CoV-2 Rapid Antigen Test (Immunochromatography Assay)

    Brief

    The SARS-CoV-2 Rapid Antigen Test (Immunochromatography Assay) adopts latex immunochromatography technology and utilizes double-antibody-sandwich method to qualitatively detect SARS-CoV-2 antigen in human nasal, nasopharyngeal or oropharyngeal swab sampled.

    Features

    Instruction

    Result interpretation

    Parameters

    Qualification CE

    Kit components

    No. Product Name Spec.
    S3120E-25 SARS-CoV-2 Rapid Antigen Test (Immunochromatography Assay) 25 tests
    The kit components:
    • SARS-CoV-2-Antigen Test Cassette (individually in a foil pouch with desiccant)
    • SARS-CoV-2 Sample Extraction Buffer
    • Swab
  • S3122E SC2 Mut2 – SARS-CoV-2 Mutation Nucleic Acid Diagnostic Kit

    Brief

    The SARS-CoV-2 Mutation Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is used to identify whether the virus contains mutation sites N501Y and HV 69-70del in nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluids, saliva and sputum from patients who have been diagnosed with SARS-CoV-2 infection.

    Performance

    • ARMS-PCR: Accurate detection of N501Y, HV 69-70delmutation sites
    • Ultra fast: Optimize testing procedures, amplification time only 60min
    • High sensitivity: Detection sensitivity reaches 200 copies/mL
    • Internal control: Rnase P, Monitor the whole process (Sampling, Extraction and Amplification )

    Parameters

    Product features Parameters
    Specimen Type Nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum
    Extraction Platform One-tube fast release technology / Advanced magnetic beads technology
    Target Genes N501Y, HV 69-70del, N gene
    Internal Control Rnase P gene
    PCR Instrument SLAN-96P, ABI7500, QuantStudio 5
    Sensitivity 200copies/mL
    Spec. 24T/48T
    Qualification CE
  • S3124E SC2 Mut5 – Detection Kit for 5 Mutations of SARS-CoV-2

    Brief

    Detection Kit for 5 Mutations of SARS-CoV-2, detects 5 SARS-CoV-2 variants, including E484K, K417N, P681H, N501Y and HV 69-70del, which covers Most Worrying Mutations.

    Performance

    • More comprehensive: Accurate detection of 5 mutation sites
    • Ultra fast: Optimize testing procedures, amplification time only 60min
    • High sensitivity: Detection sensitivity reaches 200 copies/mL
    • Internal control: Rnase P, Monitor the whole process

    Parameters

    Product features Parameters
    Specimen Type Oropharyngeal swab, sputum, alveolar lavage fluid, nasopharyngeal swab and saliva
    Extraction Platform Advanced magnetic beads technology
    Target Genes E484K, K417N, P681H, N501Y, HV 69-70del, N gene
    Internal Control Rnase P
    PCR Instrument SLAN-96P, ABI7500, QuantStudio 5
    Sensitivity 200copies/mL
    Spec. 24T/48T
    Qualification CE
  • S3113E SC2/FluA/B – SARS-CoV-2 and Influenza A/B Virus Nucleic Acid Diagnostic Kit

    Brief

    Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.   Sansure COVID-19 diagnostic solutions are used to directly detect  the presence of viral RNA, which will be detectable in patients before antibodies form or symptoms of the disease are present, which means the test results can tell whether or not that someone gets virus very early on in their illness. This kit can also joint-detect RNA of influenza A virus and influenza B virus.

    Parameters

    Product features Parameters
    Specimen Type Oropharyngeal swab, sputum
    Extraction Platform One-tube fast release technology Advanced magnetic beads technology
    Target Genes SARS-CoV-2:ORF 1ab, N gene; influenza A:M gene; influenza B:NP gene
    Internal Control Rnase P gene
    PCR Instrument ABI7500, SLAN-96P, MA-6000, QuantGene 9600, iPonatic S-Q31A&B,S-Q36A
    Sensitivity 200 copies/mL
    Spec. 24T, 48T, 24-P
    Qualification CE
  • S3123E SC2 Tri – SARS-CoV-2 Multiplex Nucleic Acid Diagnostic Kit

    Brief

    COVID-19 is an infectious disease caused by a newly discovered coronavirus named SARS-CoV2.   Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.   The SARS-CoV-2 Multiplex Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is used for qualitative detection of the ORF1ab,N and E genes of SARS-CoV-2 in nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum from patients with SARS-CoV-2 infection, suspected cases with SARS-CoV-2 infection and other patients requiring diagnosis or differential diagnosis of SARS-CoV-2 infection.

    Performance

    • Performance upgrade: ORF 1ab, N, E genes, three targets
    • High sensitivity: 200 copies/ml (one-tube fast release technology), 50 copies/ml (advanced magnetic beads method)
    • Time saving: the amplification time was 60min, and the extraction time was the shortest 30min

    Parameters

    Product features Parameters
    Specimen Type Nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum
    Extraction Platform One-tube fast release technology Advanced magnetic beads technology
    Target Genes ORF 1ab, N, E gene
    Internal Control Pseudovirus containing internal control gene fragments
    PCR Instrument SLAN-96P, ABI7500, QuantStudio 5, iPonatic S-Q31A&B
    Sensitivity 200 copies/mL (Sample Release Reagent ); 50 copies/mL (Nucleic Acid Extraction-Purification Kit )
    Spec. 24T, 48T, 96T, 12-P
    Qualification CE
  • S3148E SC2/Flu/RSV – SARS-CoV-2, Influenza Virus and Respiratory Syncytial Virus Multiple Nucleic Acid Diagnostic Kit

    ,

    Brief

    The SARS-CoV-2, Influenza Virus and Respiratory Syncytial Virus Multiple Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is a real-time RT-PCR test intended for the qualitative Diagnostic of nucleic acid from SARS-CoV-2, Influenza Virus and Respiratory Syncytial Virus Multiple in the nasopharyngeal swabs and oropharyngeal swabs from individuals.

     

    As the seventh coronavirus that infects humans, the SARS-CoV-2 can cause fever, fatigue, dry cough, dyspnea and other symptoms. In severe cases, it can cause acute respiratory distress syndrome, septic shock, and even death. At the same time, the SARS-CoV-2 has a strong spreading ability and has a wide range. Influenza virus (Influenza virus) can cause acute respiratory infections, with clinical manifestations of fever, headache, myalgia, fatigue, rhinitis, sore throat and cough. Influenza viruses can aggravate underlying diseases (such as heart and lung diseases) or cause secondary bacterial pneumonia or primary influenza viral pneumonia. The elderly and people with various chronic diseases or physical weakness are prone to severe complications and mortality higher after infecting influenza. Respiratory syncytial virus (RSV) belongs to the Pneumovirus genus of the Paramyxoviridae family. It mainly causes lower respiratory tract infections such as bronchiolitis and pneumonia in infants under 6 months, as well as rhinitis , Cold and other upper respiratory tract infections in older children and adults.

    Parameters

    Product features Parameter
    Covering pathogens
    SARS-CoV-2, Influenza Virus and Respiratory Syncytial Virus
    Specimen Types
    Nasopharyngeal swab and oropharyngeal swab
    Technical Platform
    One-tube fast release technology
    Advanced magnetic beads technology
    Internal Control
    RNase P gene
    Compatible Instrument
    ABI 7500; MA-6000; SLAN®-96P; iPonatic S-Q31A/S-Q31B/S-Q36A
    Sensitivity
    500 copies/mL.
    Qualification
    CE
  • S3102E SC2 – Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit

    ,

    Brief

    COVID-19 is an infectious disease caused by a newly discovered coronavirus named SARS-CoV2.   Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.   Sansure COVID-19 diagnostic solutions are used to directly detect  the presence of viral RNA, which will be detectable in patients before antibodies form or symptoms of the disease are present, which means the test results can tell whether or not that someone gets virus very early on in their illness.

    Performance

    • One-tube/fast release technology
    • Up to 96 samples at one time
    • Simple operation process, less specialist training
    • Room temperature lysis, less contamination
    • Sampling types : nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, sputum, serum, whole blood ,Feces
    • Enhance large-scale screening efficiency
    • Internal control: human housekeeping gene RNase P

    Parameters

    Product features Parameters
    Specimen Type Nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, sputum, serum, whole blood, feces
    Extraction Platform One-tube fast release technology Advanced magnetic beads technology
    Internal Control Rnase P gene
    PCR Instrument ABI7500, QuantStudioTM 5, SLAN-96P, MA-6000, Bio-Rad CFX-96, QuantGene 9600, LightCycler 480, iPonatic S-Q31A&B,S-Q36A
    Sensitivity 200 copies/mL
    Spec. 24T, 48T, 24-P
    Qualification CE
×
Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.
SUBMIT

Thank you!

We shall contact you soon!
Back Top